Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Corvus Pharmaceuticals (CRVS) Equity Ratio (2022 - 2025)

Historic Equity Ratio for Corvus Pharmaceuticals (CRVS) over the last 4 years, with Q3 2025 value amounting to 0.89.

  • Corvus Pharmaceuticals' Equity Ratio rose 32269.45% to 0.89 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.89, marking a year-over-year increase of 32269.45%. This contributed to the annual value of 0.47 for FY2024, which is 4434.38% down from last year.
  • As of Q3 2025, Corvus Pharmaceuticals' Equity Ratio stood at 0.89, which was up 32269.45% from 0.9 recorded in Q2 2025.
  • In the past 5 years, Corvus Pharmaceuticals' Equity Ratio ranged from a high of 0.9 in Q2 2025 and a low of 0.21 during Q3 2024
  • Over the past 4 years, Corvus Pharmaceuticals' median Equity Ratio value was 0.84 (recorded in 2023), while the average stood at 0.78.
  • Per our database at Business Quant, Corvus Pharmaceuticals' Equity Ratio crashed by 7525.59% in 2024 and then soared by 32269.45% in 2025.
  • Over the past 4 years, Corvus Pharmaceuticals' Equity Ratio (Quarter) stood at 0.82 in 2022, then grew by 3.27% to 0.85 in 2023, then plummeted by 44.34% to 0.47 in 2024, then soared by 88.69% to 0.89 in 2025.
  • Its last three reported values are 0.89 in Q3 2025, 0.9 for Q2 2025, and 0.83 during Q1 2025.